Patents by Inventor Stephanie A. Olexa

Stephanie A. Olexa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4750506
    Abstract: An apparatus for staining and destaining one or more slab gels subsequent to electrophoresis comprises a liquid impermeable enclosure having a bottom, a sidewall portion attached to the bottom and a removable top. A plurality of channels are formed in the sidewall portion of the container. At least one and preferably a plurality of cassettes are provided for retaining the slab gels. The cassettes are disposed within the channels. Each cassette comprises a pair of plates that are hinged together at one end and have a lock at the other end to secure the plates together. Each of the plates has a recess therein and a fluid permeable mesh covers each recess to form a slab gel retaining chamber therebetween. Depending upon the fluid used in the container, the slab gels can either be stained or destained. An advantage of the present apparatus is that the slab gels can be removed from the container without having to pour-off the staining or destaining solutions, thus achieving economy of material usage.
    Type: Grant
    Filed: December 24, 1986
    Date of Patent: June 14, 1988
    Inventor: Stephanie A. Olexa
  • Patent number: 4455290
    Abstract: A purified peptide isolated from fibrinogen Fragment D.sub.1 and having the amino acid sequence Thr-Arg-Trp-Tyr-Ser-Met-Lys-Lys-Thr-Thr-Met-Lys-Ile-Ile-Pro-Phe-Asn-Arg-Le u-Thr-Ile-Gly-Glu-Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-V al. The peptide is isloated by degrading Fragment D.sub.1 of fibrinogen with plasmin followed by separation of the resulting peptides on the basis of molecular weight and affinity for bound fibrin monomer. The purified peptide is useful as an anticoagulant and, when suitably labeled with a gamma-emitting radioisotope, as a thrombus imaging agent.
    Type: Grant
    Filed: April 2, 1981
    Date of Patent: June 19, 1984
    Assignee: Research Corporation
    Inventors: Stephanie A. Olexa, Andrei Z. Budzynski
  • Patent number: 4427646
    Abstract: A method of locating thrombi in vivo comprising the steps of administering a radiolabeled peptide selected from the group consisting of Fragment E.sub.1 isolated from cross-linked fibrin, Fragment E.sub.2 isolated from crosslinked fibrin, and peptides having an amino acid sequence intermediate between Fragments E.sub.1 and E.sub.2 derived from crosslinked fibrin by plasmin digestion to a human or animal wherein the peptide is selectively incorporated or bound by forming a pre-formed thrombi and externally detecting the radiation emitted by the radiolabeled peptide. A composition containing the peptide used for locating thrombi is also disclosed.
    Type: Grant
    Filed: April 2, 1981
    Date of Patent: January 24, 1984
    Assignee: Research Corporation
    Inventors: Stephanie A. Olexa, Linda C. Knight, Andrei Z. Budzynski
  • Patent number: 4390630
    Abstract: Novel fibrinolytic factors obtained from the salivary glands of Haementeria ghilianii. Proteins having molecular weights under about 100,000 are isolated from the salivary glands of H. ghilianii. The proteins show cathodic mobility in electrophoresis and uninhibited peptidase activity with fibrinogen in plasma.
    Type: Grant
    Filed: October 28, 1980
    Date of Patent: June 28, 1983
    Assignee: The Regents of the University of California
    Inventors: Roy T. Sawyer, Gunther S. Stent, Andrei Z. Budzynski, Stephanie A. Olexa